Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi Biologics Included in S&P Global Sustainability Yearbook 2025 2025-03-11 11:18
WuXi Biologics Launches EffiX™ Microbial Expression Platform to Boost Recombinant Protein and Plasmid DNA Production 2025-03-04 08:30
WuXi Biologics Again Passed GMP Inspection by Japan PMDA 2025-02-27 16:30
WuXi Biologics Again Passed GMP Inspection by Japan PMDA 2025-02-27 12:30
WuXi Biologics Awarded Platinum Medal by EcoVadis Sustainability Rating for Second Consecutive Year 2025-02-18 17:00
WuXi Biologics Recognized as Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics for Fifth Consecutive Year 2025-02-10 17:00
WuXi Biologics Announces Agreement with Candid Therapeutics on Trispecific T-cell Engager 2025-01-07 08:00
WuXi Biologics Ranks Top in 2024 Dow Jones Sustainability Indices for Second Consecutive Year 2025-01-02 17:30
WuXi Biologics Included in UNGC 20 Case Examples of Sustainable Development for 20 Years Collection 2024-12-12 16:30
WuXi Biologics Launches WuXia™ RidGS for Non-Antibiotic Cell Line Development 2024-10-28 17:00
WuXi Biologics Receives ESG Corporate Platinum Award from The Asset for Fourth Consecutive Year 2024-10-16 20:00
WuXi Biologics Included in Hang Seng ESG 50 Index 2024-09-23 17:30
WuXi Biologics Reports Solid 2024 Interim Results 2024-08-21 23:46
WuXi Biologics and Medigene Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers 2024-08-08 16:00
WuXi Biologics' Four Manufacturing Facilities and Biosafety Testing Center Certified Again by European Medicines Agency for Ten Biologics 2024-08-01 15:00
WuXi Biologics Named Constituent of the FTSE4Good Index Series for Fourth Year 2024-07-10 13:30
WuXi Biologics Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment 2024-04-30 10:55
WuXi Biologics Reports Solid 2023 Annual Results 2024-03-26 21:53
WuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change Assessment 2024-03-05 21:00
WuXi Biologics Recognized as Both Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics 2024-02-21 18:00
1 2 3 4 5 10